| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.31 | 7e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |